Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2024-05-10 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
240510 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled "Acquisition of own shares" and details the number of shares repurchased by UCB SA/NV on Euronext Brussels between May 3, 2024, and May 9, 2024, under its Share Repurchase Program 2024. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document is a disclosure of this transaction, not merely an announcement of a report.
2024-05-10 English
240510 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Rachat d'actions propres" (Share repurchase) and explicitly details the company's program for buying back its own shares, including the quantity of shares repurchased between May 3, 2024, and May 9, 2024, along with transaction prices. This activity directly corresponds to the definition of 'Transaction in Own Shares'. The filing type code for this is POS.
2024-05-10 French
240510 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Verwerving van eigen aandelen" (Acquisition of own shares) and explicitly details the number of shares repurchased by UCB NV on Euronext Brussels between May 3, 2024, and May 9, 2024, including transaction dates, quantities, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document is a direct report of the transaction, not just an announcement of a report's publication.
2024-05-10 Dutch
Minutes GM 25.04.24 - ENG - FINAL.pdf
AGM Information Classification · 100% confidence The document is the official minutes of the Annual General Meeting (AGM) of UCB SA/NV held on April 25, 2024. It details the proceedings, the bureau composition, the agenda items (such as approval of annual accounts, remuneration reports, and director appointments), and the quorum verification. This document is a record of the meeting's proceedings rather than a simple announcement of results (DVA) or a proxy solicitation (PSI). Therefore, it falls under the AGM Information category.
2024-05-08 English
Notulen AV 25.04.24 - NL - FINAL.pdf
AGM Information Classification · 100% confidence The document is titled 'NOTULEN' (Minutes) of the 'GEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS' (Ordinary General Meeting of Shareholders) for UCB NV, held on April 25, 2024. It details the proceedings, agenda items, and proposed resolutions for the AGM. As it contains the official minutes and materials related to the conduct and business of the Annual General Meeting, it is classified as AGM-R.
2024-05-08 Dutch
PV AGO 25.04.2024 - FR - FINAL.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "PROCÈS-VERBAL DE L'ASSEMBLÉE GÉNÉRALE ANNUELLE DES ACTIONNAIRES TENUE AU SIÈGE SOCIAL LE JEUDI 25 AVRIL 2024" (Minutes of the Annual General Meeting of Shareholders held at the registered office on Thursday, April 25, 2024). The content details the opening of the meeting, the constitution of the bureau, verification of proxies, and lists the agenda items which include the approval of annual accounts, remuneration reports, and the appointment/re-election of directors and the auditor. This content perfectly matches the definition of AGM materials, specifically the official minutes of the meeting.
2024-05-08 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.